Created on:
November 6, 2023

PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

Click here to download the complete article or scroll down to see the full report.